Telos works with you to clearly understand your business’ goals. We ask “Why” instead of “How.”
Our team identifies service areas where we can partner to create a plan unique to your business.
We’ll work with you through each phase to accomplish the milestones identified in the plan.
Because we see each client as a true partner, we remain ready to help your business scale as new needs arise.
Joel brings 20 years of leadership experience in the medical device industry, developing scientific and regulatory strategies for start-ups to large-cap companies. He has brought >$100 million return on investment to companies in the musculoskeletal and wound care spaces. He previously led a business development team in the application of a novel biologic material to osteoporotic patients for reducing the incidence of hip fractures; the team sold the technology for $30 million. He has also overseen key areas of investment and integration for four major acquisitions.
VP | Clinical Evidence Program
Patrick is a seasoned analytical and innovative business leader with broad experience developing clinical research strategies to ensure robust evidence generation for global market access and market development. Patrick leads the Telos contract research organization (CRO) and brings over 15 years of experience in the design and execution of clinical trials for medical devices, biologics, human tissue, and blood-based products. He has experience negotiating clinical trial design with the FDA, designing studies, and presenting results. Gathering input from regulatory, health economic, product development, scientific and marketing stakeholders, Patrick manages studies with the goal of gaining maximum value for the investment.
Jason’s background in evidence strategy and development to support approval, access, and adoption of medical devices provides a strong foundation to lead and unify Telos services and bring the greatest value to our client partners. With 10 years of experience in the fields of orthopedics and spine, he has published over 30 peer-reviewed journal articles on pre-clinical science, clinical studies, and health economics and has supported many successful regulatory submissions in the medical device industry. Jason received his PhD in biomedical engineering from the University of Rochester.
Director | Science & Innovation
Erik is a leading scientist and innovator in orthopedic and spine medical devices with over 17 years of experience designing, conducting, and communicating studies that drive value for the subject technologies and yield strong returns on investment. Erik leads the strategic development and dissemination of pre-clinical, clinical, and health economics evidence that supports marketing approvals, access, and adoption. He has published over 30 peer-reviewed articles in high-impact journals as well as 4 book chapters and has supported many successful regulatory initiatives in the medical device industry. He received his PhD in Biomedical Engineering from the University of Michigan.
Director | Regulatory & Quality Intelligence
Rebecca leads the development and implementation of regulatory strategies for global market access. With over 10 years of experience in the medical device industry, she has a track record of successful marketing applications for novel, first-of-its-kind devices, including a non-invasively adjusted growing rod for early-onset scoliosis. Rebecca works with the client to develop a customized regulatory strategy applying her strong background in quality system development to ensure the organization’s activities are meeting the ever-changing global regulatory requirements. Rebecca is a Certified Lead Auditor for ISO 13485 (Issued by BSI) and maintains her Regulatory Affairs Certification (RAC).
Founded in November 2016, after many years of working for orthopedic/spine device manufacturers and being the [often frustrated] consumers of various technical service providers, we built a technical services firm that truly partners with clients by: